![]() ![]() Include sickle cell disease, thalassemia and their variants, and hereditary spherocytosis.Īcquired hemolytic anemias may result from autoimmune disease (for example, systemic lupus erythematosus) The contents of the RBC (enzymes) and membrane. The diagnosis of hemolytic anemia is based on hemoglobin electrophoresis or analysis of Hemolytic disorders includeĪbnormalities of hemoglobin structure (hemoglobinopathies), abnormal RBC enzymeĬontent and function, and RBC membrane (envelope) defects that are congenital or acquired. In premature destruction of red blood cells (RBCs). Hemolytic anemias, both congenital and acquired, are disorders that result.What are hemolytic anemias, and how do we evaluate them under 7.05? We will not purchase complex,Ĭostly, or invasive tests, such as tests of clotting-factor proteins,Ĭ. We will make every reasonable effort to obtain the results ofĪppropriate laboratory testing you have had.With the prevailing state of medical knowledge and clinical practice. Laboratory test or tests for diagnosing your disorder and provide the results, orĮxplain how your diagnosis was established by other diagnostic method(s) consistent To be persuasive, this report must state that you had the appropriate definitive Report from a physician that a diagnosis of your hematological disorder wasĬonfirmed by appropriate laboratory analysis or other diagnostic method(s). When we do not have a laboratory report of a definitive test, a persuasive. ![]() That is not signed by a physician and a report from a physician that states you have the disorder or A laboratory report of a definitive test that establishes a hematological disorder.A laboratory report of a definitive test that establishes a hematological disorder, signed by a physician or.What evidence do we need to document that you have a hematological disorder? We need the following evidence to document that you have a hematological disorder: We evaluate primary central nervous system lymphoma associated with HIV infection under 14.11B,Īnd primary effusion lymphoma associated with HIV infection under 14.11C.ī. We evaluate malignant (cancerous) hematological disorders, such as lymphoma, leukemia, and multiple myeloma,Įxcept for two lymphomas associated with human immunodeficiency virus (HIV) infection.These disorders disrupt the normal development and function of white blood cells, red blood cells, platelets, and clotting-factor proteins (factors). We evaluate non-malignant (non-cancerous) hematological disorders, such as hemolytic anemias ( 7.05),ĭisorders of thrombosis and hemostasis ( 7.08), and disorders of bone marrow failure ( 7.10).What hematological disorders do we evaluate under these listings? ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |